Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies

被引：40
作者：
Calvert, AH [1 ]
Egorin, MJ [1 ]
机构：
[1] Univ Newcastle, Sch Med, Dept Oncol, Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷 / 01期
关键词：
D O I：
10.1016/S0959-8049(01)00340-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：11 / 16
页数：6
相关论文
共 52 条
[31]   RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND TUMOR RESPONSE AND TOXICITY IN PATIENTS WITH OVARIAN-CANCER [J].
JODRELL, DI ;
EGORIN, MJ ;
CANETTA, RM ;
LANGENBERG, P ;
GOLDBLOOM, EP ;
BURROUGHS, JN ;
GOODLOW, JL ;
TAN, S ;
WILTSHAW, E .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :520-528
[32]  
Johnsson A, 1998, CANCER CHEMOTH PHARM, V41, P248
[33]  
Korst AEC, 1997, CLIN CANCER RES, V3, P697
[34]   Calvert's formula for dosing carboplatin: Overview and concerns of applicability in high-dose setting [J].
Mazumdar, M ;
Smith, A ;
Tong, WP ;
Motzer, RJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (17) :1434-1436
[35]  
Miyazaki M, 1997, ANTICANCER RES, V17, P4571
[36]   CARBOPLATIN PHARMACOKINETICS IN CHILDREN - THE DEVELOPMENT OF A PEDIATRIC DOSING FORMULA [J].
NEWELL, DR ;
PEARSON, ADJ ;
BALMANNO, K ;
PRICE, L ;
WYLLIE, RA ;
KEIR, M ;
CALVERT, AH ;
LEWIS, IJ ;
PINKERTON, CR ;
STEVENS, MCG .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (12) :2314-2323
[37]   Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae [J].
Okamoto, H ;
Nagatomo, A ;
Kunitoh, H ;
Kunikane, H ;
Watanabe, K .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (04) :307-312
[38]   A limited-sampling model for the pharmacokinetics of carboplatin administered in combination with paclitaxel [J].
Panday, VRN ;
van Warmerdam, LJC ;
Huizing, MT ;
Huinink, WWT ;
Schellens, JHM ;
Beijnen, JH .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (11) :615-620
[39]   IMPACT OF CYCLOPHOSPHAMIDE ON RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND RESPONSE OR TOXICITY WHEN USED IN THE TREATMENT OF ADVANCED OVARIAN-CANCER [J].
REYNO, LM ;
EGORIN, MJ ;
CANETTA, RM ;
JODRELL, DI ;
SWENERTON, KD ;
PATER, JL ;
BURROUGHS, JN ;
NOVAK, MJ ;
SRIDHARA, R .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) :1156-1164
[40]   A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer [J].
Sculier, JP ;
Paesmans, M ;
Thiriaux, J ;
Lecomte, J ;
Bureau, G ;
Giner, V ;
Koumakis, G ;
Lafitte, JJ ;
Berchier, MC ;
Alexopoulos, CG ;
Zacharias, C ;
Mommen, P ;
Ninane, V ;
Klastersky, J .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (09) :1314-1319
123456